Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial (Q33342491)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial |
scientific article |
Statements
1 reference
Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial (English)
1 reference
1 reference
David J Moliterno
1 reference
Gregg W Stone
1 reference
Kathy Wolski
1 reference
Franz-Josef Neumann
1 reference
Eric A Cohen
1 reference
Jeffrey W Moses
1 reference
Howard C Herrmann
1 reference
Eric R Powers
1 reference
Cindy L Grines
1 reference
Peter M DiBattiste
1 reference
Michel Bertrand
1 reference
David J Cohen
1 reference
Marc Cohen
1 reference
Identifiers
1 reference